EUVIMEDObjevte EUVIMED
Crossref

Non‐Oncocytic Thyroid Follicular Neoplasm: Cytological Atypia and Development of a Score for Malignancy Risk Stratification

Boris M Shifman iD, Nadezhda M Platonova iD, Fatima M Abdulkhabirova iD, Ekaterina V Bondarenko iD, Anastasia M Lapshina iD, Liliya S Urusova iD, Georgii S Razmakhaev iD, Tatyana N Kamneva iD, Ekaterina A Troshina iD

Diagnostic Cytopathology · 2026-12 · 54 (12) · 881-900

DOI: 10.1002/dc.70196 ↗

At a glance

Journal article in Diagnostic Cytopathology, published online on 2026-08-25. Written by Boris M Shifman and 8 co-authors. Institution: Endocrinology Research Centre, Moscow, Russia. Major MEDLINE topics: Thyroid Neoplasms, Adenocarcinoma, Follicular. 28 references. Funded by: Ministry of Health of the Russian Federation.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Cytological diagnosis of follicular neoplasm (FN; Bethesda IV) is associated with intermediate malignancy risk. Further stratification based on cytological features may be particularly relevant for non‐oncocytic FN but requires reliable, reproducible assessment approaches. This study evaluated cytological features of non‐oncocytic FN in terms of interobserver agreement and association with malignancy risk, and developed a cytological atypia scoring system for risk stratification.

Methods

This cross‐sectional study included adult patients who underwent surgery for non‐oncocytic FN. Cytological slides were independently reviewed by five cytopathologists. Fifteen cytological features were assessed; interobserver agreement and feature frequencies across histological outcome groups were evaluated.

Results

The final cohort included 200 cases: 80 malignant, 80 benign, and 40 low‐risk lesions. Eight cytological features showed acceptable interobserver agreement and different degrees of association with malignancy and were incorporated into the scoring system. The cytological atypia score was higher in malignant than in low‐risk and benign groups ( p < 0.001). ROC analysis yielded an AUC of 0.70 (95% CI, 0.63–0.76). Scores ≥ 4 points were associated with higher malignancy risk than scores of 0–3 points (OR = 3.87; 95% CI, 2.01–7.44; p < 0.001). An additional ≥ 8‐point threshold identified a high‐score subgroup with markedly increased malignancy risk compared with the 0–3‐point subgroup (OR = 9.22; 95% CI, 3.43–24.77; p < 0.001). Cytological atypia did not distinguish low‐risk tumours from benign lesions.

Conclusion

The most reproducible cytological features associated with malignancy risk were identified, and the proposed scoring system enabled stratification of non‐oncocytic FN by malignancy risk, potentially supporting individualised risk assessment after further validation.

Subjects

MeSH terms (MEDLINE)

Thyroid NeoplasmsAdenocarcinoma, FollicularHumansFemaleAdultMiddle AgedMaleCross-Sectional StudiesRisk AssessmentBiopsy, Fine-NeedleAgedObserver Variation

Author keywords

Bethesda IVcytological risk stratificationfine‐needle aspiration cytologyfollicular neoplasminfrequent scenario of follicular neoplasminterobserver agreementthyroid nodule

Authors and institutions

  • Endocrinology Research Centre, Moscow, Russia.

ORCID profiles: Boris M Shifman, Nadezhda M Platonova, Fatima M Abdulkhabirova, Ekaterina V Bondarenko, Anastasia M Lapshina, Liliya S Urusova, Georgii S Razmakhaev, Tatyana N Kamneva, Ekaterina A Troshina

Funding

  • Ministry of Health of the Russian Federation

Cite

APA

Shifman, B. M., Platonova, N. M., Abdulkhabirova, F. M., Bondarenko, E. V., Lapshina, A. M., Urusova, L. S., Razmakhaev, G. S., Kamneva, T. N., & Troshina, E. A. (2026). Non‐Oncocytic Thyroid Follicular Neoplasm: Cytological Atypia and Development of a Score for Malignancy Risk Stratification. Diagnostic Cytopathology, 54(12), 881-900. https://doi.org/10.1002/dc.70196

Vancouver

Shifman BM, Platonova NM, Abdulkhabirova FM, Bondarenko EV, Lapshina AM, Urusova LS, et al. Non‐Oncocytic Thyroid Follicular Neoplasm: Cytological Atypia and Development of a Score for Malignancy Risk Stratification. Diagnostic Cytopathology. 2026;54(12):881-900. doi:10.1002/dc.70196

BibTeX
@article{Shifman2026,
  author = {Shifman, Boris M and Platonova, Nadezhda M and Abdulkhabirova, Fatima M and Bondarenko, Ekaterina V and Lapshina, Anastasia M and Urusova, Liliya S and Razmakhaev, Georgii S and Kamneva, Tatyana N and Troshina, Ekaterina A},
  title = {Non‐Oncocytic Thyroid Follicular Neoplasm: Cytological Atypia and Development of a Score for Malignancy Risk Stratification},
  journal = {Diagnostic Cytopathology},
  year = {2026},
  volume = {54},
  number = {12},
  pages = {881--900},
  doi = {10.1002/dc.70196}
}
Start for free →